Additionally, Rojas et al.’s study involving ERBB3 deletions revealed that cancers had increased EGFR expression when HER3 was not present and that tumors with ERBB3 deleted were smaller than those with ERBB3 present [92]. The gene discussed is ERBB3; the disease is cancer.